|
Hypertrophy
Citations 311-320 of 487 total displayed.
|
Past content
(since Jan 1999):
|
- Cardiology Patient Pages
What Is an Angiotensin Converting Enzyme Inhibitor?
- Nancy K. Sweitzer
Circulation 2003;108:e16-18e, doi:10.1161/01.CIR.0000075957.16003.07
[Full text]
- Articles
Activation and Functional Significance of the Renin-Angiotensin System in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor
- Markus Flesch, Anje Höper, Louis Dell'Italia, Kenda Evans, Richard Bond, Ronald Peshock, Abhinav Diwan, Theresa A. Brinsa, Chih-Chang Wei, Natarajan Sivasubramanian, Francis G. Spinale, and Douglas L. Mann
Circulation published July 21, 2003, doi:10.1161/01.CIR.0000081768.13378.BF
[Abstract]
- Articles
Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy
- Sara L. Van Driest, Erik G. Ellsworth, Steve R. Ommen, A. Jamil Tajik, Bernard J. Gersh, and Michael J. Ackerman
Circulation published July 14, 2003, doi:10.1161/01.CIR.0000080896.52003.DF
[Abstract]
- Articles
Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy
- Markus P. Schlaich, David M. Kaye, Elisabeth Lambert, Marcus Sommerville, Flora Socratous, and Murray D. Esler
Circulation published July 7, 2003, doi:10.1161/01.CIR.0000081775.72651.B6
[Abstract]
- Editorials
Why Angina in Aortic Stenosis With Normal Coronary Arteriograms?
- K. Lance Gould and Blase A. Carabello
Circulation 2003;107:3121-3123, doi:10.1161/01.CIR.0000074243.02378.80
[Full text]
- Clinical Investigations and Reports
Functional Changes in Coronary Microcirculation After Valve Replacement in Patients With Aortic Stenosis
- Kim Rajappan, Ornella E. Rimoldi, Paolo G. Camici, Nicholas G. Bellenger, Dudley J. Pennell, and Desmond J. Sheridan
Circulation 2003;107:3170-3175; published online before print as doi:10.1161/01.CIR.0000074211.28917.31
[Abstract]
[Full text]
- Images in Cardiovascular Medicine
Covered Stent Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Initial Success but Ultimate Failure Resulting From Collateral Formation
- Michael A. Fifer, Danita M. Yoerger, Michael H. Picard, Gus J. Vlahakes, and Igor F. Palacios
Circulation 2003;107:3248-3249, doi:10.1161/01.CIR.0000068035.52761.71
[Full text]
- Correspondence
Transient Limb Ischemia Induces Remote Ischemic Preconditioning In Vivo • Response
- David A. Liem, Pieter D. Verdouw, Dirk J. Duncker, R.K. Kharbanda, A. Hoschtitzky, M. Vogel, R. MacAllister, U.M. Mortensen, S. Kristiansen, M. Schmidt, K.E. Sorensen, P.A. White, and A. Redington
Circulation 2003;107:e218-219e, doi:10.1161/01.CIR.0000077520.36997.F9
[Full text]
- Clinician Update
Primary Prevention of Sudden Death as a Novel Treatment Strategy in Hypertrophic Cardiomyopathy
- Barry J. Maron, N. A. Mark Estes, III, Martin S. Maron, Adrian K. Almquist, Mark S. Link, and James E. Udelson
Circulation 2003;107:2872-2875, doi:10.1161/01.CIR.0000072343.81530.75
[Full text]
- Correspondence
Endothelin Receptor Blockade and Exacerbation of Heart Failure
- István Szokodi, Jarkko Piuhola, and Heikki Ruskoaho
Circulation 2003;107:e211, doi:10.1161/01.CIR.0000075859.90953.5A
[Full text]
|
|
